Hepatic spiral CT: reduction of dose of intravenous contrast material

Radiology. 1995 Oct;197(1):83-8. doi: 10.1148/radiology.197.1.7568859.

Abstract

Purpose: To assess the potential for reduction of contrast material dose in hepatic spiral computed tomography (CT).

Materials and methods: Four hundred eighty-seven outpatients were randomized prospectively into nine biphasic and eight uniphasic injection protocols: 75, 100, or 125 mL of 240, 300, or 350 mg of iodine per milliliter of iohexol (18-44 grams of iodine). Protocols were compared according to the maximum hepatic enhancement (MAX) and the contrast enhancement index (CEI).

Results: Uniphasic injection was superior to biphasic injection for all protocols. No statistically significant difference in contrast enhancement was present for 38-44 grams of iodine with the uniphasic technique. Adequate enhancement thresholds (MAX > 50 HU, CEI at 30 HU > 300 HU x sec) were exceeded in more than 70% of heavy patients ( > 183 lb [83 kg]) with uniphasic injection of 38 g. For thin patients ( < 183 lb [83 kg]), uniphasic injection of 26 g produced adequate enhancement.

Conclusion: Contrast material dose may be reduced by up to 40% in thin patients undergoing hepatic spiral CT after uniphasic injection of contrast material; this may result in substantial cost savings.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Contrast Media / administration & dosage*
  • Female
  • Humans
  • Injections, Intravenous
  • Iohexol / administration & dosage*
  • Liver / diagnostic imaging*
  • Male
  • Middle Aged
  • Prospective Studies
  • Tomography, X-Ray Computed*

Substances

  • Contrast Media
  • Iohexol